OPR - Delayed Quote • USD TMCI Sep 2024 20.000 call (TMCI240920C00020000) Follow 1.6700 0.0000 (0.00%) As of February 13 at 10:23 AM EST. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for TMCI240920C00020000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: TMCI Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour Treace to Present at Bank of America Health Care Conference Treace Announces First Annual National Bunion Day Treace to Report First Quarter 2024 Financial Results Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported And Analysts Have Been Lifting Their Price Targets Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call Transcript Treace Medical Concepts Full Year 2023 Earnings: EPS Misses Expectations Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates Treace Medical Concepts Inc (TMCI) Reports Robust Revenue Growth and Expands Surgeon Base in Q4 ... Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance Earnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to Decline
